 BOSTON, Aug. 02, 2021 GLOBE NEWSWIRE -- Sensei Biotherapeutics, Inc. NASDAQ: SNSE, an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointment of Kristian Humer, former managing director of Banking, Capital Markets Advisory for the Global Healthcare team at Citigroup, Inc. as an independent director to the companys board of directors, effective July 30, 2021. 